Reperfusion paradox in ST-segment elevation myocardial infarction.

Area of Science:

• Cardiology
• Emergency Medicine
• Public Health

Background:

• ST-segment elevation myocardial infarction (STEMI) care has shifted towards primary percutaneous coronary intervention (PPCI).
• PPCI demonstrates superior reperfusion compared to fibrinolysis in STEMI patients.
• Most STEMI patients present to hospitals without 24/7 PPCI capabilities, leading to delays.

Purpose of the Study:

• To address the treatment paradox where efforts to improve PPCI lead to delays in other therapies for STEMI.
• To highlight the unfavorable consequences of delayed PPCI in STEMI management.
• To advocate for an integrated dual reperfusion strategy for all STEMI patients.

Main Methods:

• Review of current STEMI treatment guidelines and national care programs.
• Analysis of evidence regarding the outcomes of delayed PPCI versus early fibrinolysis.
• Evaluation of prehospital fibrinolysis combined with mechanical co-interventions.

Main Results:

• Delayed PPCI in STEMI patients presenting to non-PPCI centers often results in denial of timely pharmacologic therapy.
• Recent evidence confirms negative outcomes associated with delayed PPCI.
• Early prehospital fibrinolysis coupled with strategic mechanical interventions shows excellent results.

Conclusions:

• The current approach to STEMI care creates a paradox, delaying beneficial treatments like fibrinolysis.
• An integrated dual reperfusion strategy, combining early fibrinolysis with timely mechanical interventions, is recommended.
• This integrated approach aims to optimize outcomes for all STEMI patients, regardless of initial hospital capabilities.